Synlogic
$1.859876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.16 (-7.96%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Synlogic and other stocks, options, ETFs, and crypto commission-free!
About SYBX
Synlogic, Inc. Common Stock, also called Synlogic, is a clinical-stage biopharmaceutical company. Read More It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.
Employees
76
Headquarters
Cambridge, Massachusetts
Founded
2017
Market Cap
63.21M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
316.16K
High Today
$1.96
Low Today
$1.83
Open Price
$1.94
Volume
108.59K
52 Week High
$10.01
52 Week Low
$1.35
Collections
Analyst Ratings
75%
of 8 ratings
Buy
75%
Hold
13%
Sell
13%
SYBX Earnings
-$0.63
-$0.42
-$0.21
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours